SureNano Initiates $1.25 Million Private Placement to Fuel Growth

SureNano Science Ltd. has announced plans for a private placement aimed at raising up to $1.25 million. The Vancouver-based company intends to sell up to 10 million units at a price of $0.125 per unit. Each unit will consist of one common share and a warrant, which will allow the holder to purchase one additional common share for $0.35 over a period of 24 months following issuance.

The private placement’s structure includes an acceleration provision. If the company’s shares trade at or above $0.50 for ten consecutive trading days after a four-month period, SureNano may expedite the expiry of the warrants. Holders would then have 30 days from the notice date to exercise their warrants.

To facilitate this process, finders may receive a commission comprising 6% cash and 6% common share purchase warrants, also set to be exercisable at $0.35 for two years. Proceeds from the private placement will be allocated towards operating expenses, including legal and audit fees, and will also support efforts to explore new markets for the SureNano™ surfactant and identify complementary industries.

The securities issued will be subject to a hold period of four months and one day, as per regulatory requirements.

About SureNano Science Ltd.

SureNano Science Ltd. specializes in the sale and distribution of the SureNano™ surfactant, which is a food-grade compound designed for high-performance nanoemulsions. This product aims to enhance the stability, clarity, and taste of various formulations while maximizing bioavailability. SureNano holds an exclusive license to distribute the surfactant within Canada, as well as in Oklahoma and Colorado in the USA.

CEO Charles MaLette leads the company, steering it towards innovative applications and market expansion.

The announcement comes on November 5, 2025, and reflects SureNano’s ongoing commitment to growth and innovation in the surfactant industry.

While the private placement is a strategic move to secure funding, potential investors should consider the inherent risks associated with such investments. Forward-looking information included in this release is based on management’s expectations and assumptions, which may not prove to be accurate.

The Canadian Securities Exchange (CSE) has not reviewed the details of this release and does not take responsibility for its accuracy.

For further information, interested parties can reach out to SureNano at the following contact:

Charles MaLette
CEO, President, Director & Secretary
Phone: 604-428-5171
Email: [email protected]

This announcement highlights SureNano’s proactive steps in a competitive market, marking a significant phase in its growth trajectory.